Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
Active, not recruiting · NCT06237920 · Registry updated 2026-07-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Active, not recruiting | Phase 2 | 2026-07-15 | NCT06237920 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| The Netherlands Cancer Institute | 113 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdam UMC (AUMC) | Amsterdam | Netherlands | 1 |
| Erasmus Medical Center | Rotterdam | Netherlands | 1 |
| Isala | Zwolle | Netherlands | 5 |
| Leiden University Medical Center (LUMC) | Leiden | Netherlands | 4 |
| NKI-AVL | Amsterdam | Netherlands | 3 |
| Radboud University Medical Center | Nijmegen | Netherlands | 6 |
| Rijnstate | Arnhem | Netherlands | 2 |
| Spaarne Gasthuis | Hoofddorp | Netherlands | 1 |
| University Medical Center Utrecht | Utrecht | Netherlands | 7 |